Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia

CAPÍTULO 1.

OMS. I Seminario Taller de identificación de necesidades de investigación en reproducción humana en Colombia. Cartagena, 1990.

DANE. Proyecciones de Población, Bogota, D.C., República de Colombia.

ENDS/2000. Profamilia Pg. 40-42- ENDS/2005, Bogotá D.C.

DANE. Mortalidad en Colombia, 1998, Bogotá D.C.

Nuckolls KB. Psychosocial assets, life crisis and the prognosis of pregnancy. Am J Epidemiol 1972; 95, 431 - 41.

https://doi.org/10.1093/oxfordjournals.aje.a121410

Obayuwana AO. Psychosocial distress and pregnancy outcome: a prospective study. J Psychos Obstet Gynecol 1984; 3: 173 - 83. https://doi.org/10.3109/01674828409017459

Ramsey CH. The relationship between family functioning, life events, family structure, and the outcome of pregnancy. J Fam Pract 1986; 521 - 25.

Smilkstein G. Predictions of pregnancy complication of the biopsychosocial model. Soc Sci Med 1984: 315 - 21.

https://doi.org/10.1016/0277-9536(84)90120-5

Herrera JA, Hurtado H, Cáceres D., Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391 - 99.

Herrera JA, Cáceres D., Hurtado H. Aplicación de un modelo biopsicosocial en la predicción de complicaciones perinatales. Med Fam 1994, 6: 42 - 6.

Herrera JA, Alvarado JP, Restrepo W. Riesgo biopsicosocial prenatal y preeclampsia. Aten Prim 1995, 16: 552 - 55.

Herrera JA, Salmerón B, Hurtado H. The prenatal biopsychosocial risk and low birthweight. Soc Sci Med 1997; 44: 8, 1107 - 1114. https://doi.org/10.1016/S0277-9536(96)00240-7

Herrera JA, Erscheng G, Shahabuddin AKM et al. Riesgo biopsicosocial en la predicción de las complicaciones maternas y perinatales en países asiáticos 2002- 2003. Colombia Med 2006, 37 (1S): 1-8.

Herrera JA. La Mortalidad perinatal y el modelo biopsicosocial. Experiencias institucionales en Colombia. Med Fam 1992;4:98 - 102.

Dunbar F. Psychosomatic medicine. New York. Random House 1947.

Gorsuch RL, Key MK. Abnormalities of pregnancy as a function of anxiety and life stress. Psychosom Med 1974; 36:352 - 62. https://doi.org/10.1097/00006842-197407000-00009

Yamamoto KJ, Kinney DK. Pregnant women ratings of different factors influencing psychological stress during pregnancy. Psychol Rep 1976; 39:203 -14. https://doi.org/10.2466/pr0.1976.39.1.203

Williams CC,Williams RA, Griswold MJ et al. Pregnancy and life change. J Psychosom Res 1975;123 - 29.

https://doi.org/10.1016/0022-3999(75)90059-8

Schwartz JL. A study of relationship between maternal life-change events and premature delivery. In: Schwartz JL, Schwartz LH (eds). Vulnerable infants: a psychosocial dilema. New York, McGraw Hill, 1977.

Kapp FT, Hornstein S, Graham V. Some psychosocial factors in prolonged labor due to inefficient uterine action. Comp Psych 1963;4: 913. https://doi.org/10.1016/S0010-440X(63)80066-8

Crandon AJ. Maternal anxiety and obstetric complications. J Psychosom Res 1979; 23: 109 - 111.

https://doi.org/10.1016/0022-3999(79)90014-X

Smilkstein G, Helsper-Lucas A, Ashworth C et al. Predictions of pregnancy complications: an application of the biopsychosocial model. Soc Sci Med 1984; 18: 315 - 21. https://doi.org/10.1016/0277-9536(84)90120-5

Hetzal BS, Bruer B, Poivedeau LS. A survey of the relation between certain common antenatal complications. In primiparae and the stressfull life situations during pregnancy. J Psychosom Res 1961; 5: 175 - 82.

https://doi.org/10.1016/0022-3999(61)90044-7

Muller-Tyl N, Wimmer-Puchinger BP. Psychosomatic aspects of toxemia. J Psychosom Obstet Gynecol 1982; 1: 111 - 17. https://doi.org/10.3109/01674828209081239

Herrera JA, Alvarado JP, Martinez JE. The psychosocial environment and the cellular immunity in the pregnant patient. Stress Med 1988; 4: 2 - 10. https://doi.org/10.1002/smi.2460040109

Herrera JA, Hurtado H, Cáceres D. Aplicación de un Modelo Biopsicosocial para la Reducción de la Morbilidad y la Mortalidad Materna y Perinatal en Colombia. Ed Trazo 1997, 1a Ed. Bogotá, D.C.

CAPÍTULO 2.

República de Colombia. Ministerio de Salud. La mortalidad materna en Colombia. Agosto, 1996.

Herrera JA. Epidemiología de preeclampsia. Colombia Med 1994; 25: 151-553.

Friedman J. Pathology of preeclampsia. Clin Perinatol 1991; 18: 661-82. https://doi.org/10.1016/S0095-5108(18)30490-1

Ilekis JV, Reddy UM, Roberts JM. Preeclampsia a pressing problem: an executive summary of a National Institute of Child health and Human Development workshop. Reprod Sci 2007; 14(6): 508-23.

https://doi.org/10.1177/1933719107306232

Goodman RP, Killan AP, Brash AR. Prostacyclin production during pregnancy complicated by hypertension. Am J Obstet Gynecol 1982; 142: 817-22. https://doi.org/10.1016/S0002-9378(16)32525-X

Brown JJ, Davies PB. Doak AF et al. Plasma renin concentration in hypertensive disease of pregnancy. Lancet 1965; 2: 1219. https://doi.org/10.1136/bmj.2.5472.1215

Mäkíla UM, Viinika L., Ylilorkala E et al. Increase Thromboxane A2 production but normal prostacyclin by the placenta in hypertensive pregnancies. Prostaglandins 1984; 27: 87 -95. https://doi.org/10.1016/0090-6980(84)90222-3

Stuart MJ, Sunderji SG, Yambo T et al. Decrease prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet 1981; 1: 1126 - 28. https://doi.org/10.1016/S0140-6736(81)92298-4

Bussolino F, Benedetto G, Massobri M. et al. Maternal vascular prostacyclin activity in preeclampsia. Lancet 1980; 2:702. https://doi.org/10.1016/S0140-6736(80)92746-4

Langford HG, Douglas BH, Arhelger RB. A model of preeclampsia: 1. Blood pressure changes produced by antiplacental serum. Jhons Hopkins Med J 1967; 120: 220 - 24.

Roberts JM. Taylor RN, Musci TJ. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-04. https://doi.org/10.1016/0002-9378(89)90665-0

Brown JJ, Davies PB, Doak AF et al. Plasma renin concentration in hypertensive disease of pregnancy. Obstet Gynaecol Br Comonwealth 1966; 73: 410- 14. https://doi.org/10.1111/j.1471-0528.1966.tb05181.x

Brown JJ, Davies PB, Doak AF et al. Plasma renin concentration in hypertensive disease of pregnancy. Lancet 1965; 2:1219. https://doi.org/10.1016/S0140-6736(65)90639-2

Kupferminc MJ, Peaceman AM, Wington TR, Tamura RK, Rehnberg KA, Socol ML: Inmunoreactive tumor necrosis factor-α is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am J Obstet Gynecol 1994; 171: 976-979. https://doi.org/10.1016/0002-9378(94)90017-5

Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive citokynes in women with preeclampsia. Am J Reprod Immunol 1998; 40:102-11. https://doi.org/10.1111/j.1600-0897.1998.tb00398.x

López-Jaramillo P, Escudero C, Moya W: Markers of systemic inflammation and nitric oxide metabolites in preeclampsia. Nitric Oxide Biol Chem 1998; 2: 127.

Vince GS, Starkey PM, Austgulen R: Interleukin-6, tumor necrosis factor and soluble receptors in women with preeclampsia. Br J Obstet Gynaecol 1995; 102: 20-25. https://doi.org/10.1111/j.1471-0528.1995.tb09020.x

Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, et al: Evidence for elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Inmunol 1997; 38: 89-93. https://doi.org/10.1111/j.1600-0897.1997.tb00281.x

Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML: Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420-427. https://doi.org/10.1016/0029-7844(96)00179-2

Teran E, Escudero C, Moya W, Flores M, Vallance P, López-Jaramillo P: Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynecol Obstet. 2001; 75:243-249.

https://doi.org/10.1016/S0020-7292(01)00499-4

Greer IA, Lyall F, Perera T, Boswell F, Macara LM: Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994; 84: 937-940.

Hill JA, Devoe L, Bryans C: Frequency of asymptomatic bacteriuria in preeclampsia. Obstet Gynecol 1986; 67: 529-532.

Contreras A, Herrera JA, Soto JE, Arce RM, Jaramillo A, Botero JE. Periodontitis is associated with preeclampsia in pregnant women: A case-control study. J Periodont 2006; 77:182-88. https://doi.org/10.1902/jop.2006.050020

Herrera JA, Parra B, Herrera E, Arce R, López- Jaramillo P, Contreras A. Periodontal disease severity is related to high levels of C-reactive protein in preeclampsia. J Hypert 2007 25(7):1459-1464. https://doi.org/10.1097/HJH.0b013e3281139ea9

Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of IL-10 in preeclampsia. J Immunol 1999; 163:3491-5.

Piccinni MP, Maggi E, Romagnani S. Role of the hormone-controlled T-cell cytokines in the maintenance of pregnancy. Biochemical Social Trans 2000; 28:212-5. https://doi.org/10.1042/bst0280212

Coussons-Read ME, Okun M, Simms S. The psychoneuroimmunology of pregnancy. J Reprod Inf Psych 2003; 21:103-12. https://doi.org/10.1080/0264683031000124064

Coussons-Read ME, Okun ML, Glese S. Prenatal stress cytokine levels in a manner that may endanger human pregnancy. Psychosom Med 2005; 67 (4):625-31. https://doi.org/10.1097/01.psy.0000170331.74960.ad

Coussons-Read M, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun 2007; 21 (3): 343-50. https://doi.org/10.1016/j.bbi.2006.08.006

Herrera JA & Hurtado H, Cáceres D. Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391-399. Preeclampsia enfermedad trazadora de mortalidad materna y perinatal 60 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia

Herrera JA Salmerón B., Hurtado H. The biopsychosocial risk assessment and the low birthweight. Soc Sci Med 1997; 44:8, 1107-14. https://doi.org/10.1016/S0277-9536(96)00240-7

Herrera JA, Alvarado JP & Restrepo W. Riesgo biopsicosocial prenatal y preeclampsia. Atenc Primaria 1995; 16:9,552-55.

Haelterman E, Marcoux S, Croteau A, Dramaix M. Population-based study on occupational risk factors for preeclampsia and gestational hypertension. Scand J Work Environ Health 2007; 33(4):304-17. https://doi.org/10.5271/sjweh.1147

Hegaard HK, Pederson BK, Nielsen BB, Damm P. Leisure time physical activity during pregnancy and impact on gestational diabetes mellitus, preeclampsia, preterm birth weight: a review. Acta Obstet Gynecol Scand 2007;86(11):1290-6. https://doi.org/10.1080/00016340701647341

Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007; 334 (4):291-5. https://doi.org/10.1097/MAJ.0b013e3180a6f094

Goldenberg R, Cliver SD, Bronstein J et al. Bed rest in pregnancy. Obstet Gynecol 1994; 84:131-35.

Gant NF, Chand S. A study of angiostensin II pressor responsiveness throught out primigravid pregnancy. J Clin Invest 1973; 52: 2689. https://doi.org/10.1172/JCI107462

Aiken JW, Vane J. Intrarenal prostagandin release attenuates the renal vasoconstriction activity of angiotensin. J Pharmacol Exp Ther 1973; 184: 678.

Herrera JA Arévalo- Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation: A randomized controlled trial . Obstet & Gynecol 1998; 91; 585-90. https://doi.org/10.1016/S0029-7844(97)00711-4

Belizan JM, Villar J, Salazar A, et al. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. Am J Obstet Gynecol 1983; 146: 175-80. https://doi.org/10.1016/0002-9378(83)91049-9

Levine RJ, Hauth JC, Curet LB. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337: 69-75.

https://doi.org/10.1056/NEJM199707103370201

World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006 194(3):639-49. https://doi.org/10.1016/j.ajog.2006.01.068

Repke JT. Calcium, magnesium and zinc supplementation and perinatal outcome. Clin Obstet Gynecol 1991; 34- 262. https://doi.org/10.1097/00003081-199106000-00006

Herrera JA, Arévalo-Herrera M, Villegas A, Herrera S, Villalba M, Bromet A. Suplementación oral de calcio en adolescentes embarazadas de bajo nivel socioeconómico y su efecto en las concentraciones de calcio libre intracelular. Colombia Med 2006, 37 (S1): 9-15.

Belizan JM, Villar J, González M. Calcium supplementattion during pregnancy: A systematic review of randomised controlled trials. Br Obstet Gynecol 1994; 101: 1-6. 61

Imperiale TF, Petrulis AS. A meta-analysis of low dose aspirin for the prevention of pregnancy induced hypertensive disease. JAMA 1991; 66: 60-4.

Leltich H. Egarter C, Husselein P et al. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynecol 1997; 104: 450-9. https://doi.org/10.1111/j.1471-0528.1997.tb11497.x

Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; Paris Collaborative Group. Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet 2007; 369 (9575):1791-8. https://doi.org/10.1016/S0140-6736(07)60712-0

Duley L, Henderson-Smart DJ, King JF. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2007; 18(2):CD004659. https://doi.org/10.1002/14651858.CD004659.pub2

Wen WS, Chen XK, Rodger M, White RR, Yang Q, Smith GN et al. Folic acid supplementation in early second trimestre and the risk of preeclampsia. Am J Obstet Gynecol 2008; 198:45-7 53. https://doi.org/10.1016/j.ajog.2007.06.067

Herrera JA. Nutritional factors and rest reduce pregnancy-induced hypertension and preeclampsia in positive roll-over test primigravids. Int J Obstet Gynecol 1990; 76: 742-44.

Aplicación de un modelo biopsicosocial para la reducción de la mortalidad materna y perinatal en Colombia. Trazo Ed. 1997, 1a Ed. Bogotá, D.C.

Herrera JA, Chaudri G, López- Jaramillo P. Is infection a major risk factor for preeclampsia? Med Hypoth 2001; 57:393-7. https://doi.org/10.1054/mehy.2001.1378

Herrera JA, Shahabuddin AKM, Ersheng G , Wei Y, García R, López- Jaramillo P. Calcium plus linoleic acid therapy for pregnancy-induced hypertension. Int J Obstet Gynecol 2005. 91: 221-227. https://doi.org/10.1016/j.ijgo.2005.08.018

Herrera JA, Arevalo-Herrera M, Shahabuddin AKM, Ersheng G , Herrera S, Garcia R, López- Jaramillo P. Calcium and conjugated linoleic acid reduces pregnancyinduced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypert 2006; 19:381-87. https://doi.org/10.1016/j.amjhyper.2005.11.004

Bánhidy F, Acs N, Puhó EH, Czeizel AE. Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments. Scand J Infect Dis 2007; 39 (5):390-7. https://doi.org/10.1080/00365540601087566

Roberts JM, Taylor RM, Goldfein A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypert 1991; 4:700-8.

Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198(1):7-22. Preeclampsia enfermedad trazadora de mortalidad materna y perinatal 62 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia.

García RJ, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F, ArenasMantilla M, López-Jaramillo P. Raised C-reactive protein and impaired flowmediated vasodilation precede the development of preeclampsia. Am J Hypertens 2007 20:98-103.

Bisoendial RJ, Kastelein JJ, Stroes S. C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis 2007; 195 (2): e10-8. https://doi.org/10.1016/j.atherosclerosis.2007.04.053

Herrera JA. La mortalidad perinatal y el modelo biopsicosocial. Experiencias institucionales en Colombia. Atención Prim 1992; 10: 992.

CAPÍTULO 3:

Erickson JD, Bjerkedal T. Fetal and infant mortality in Norway and the United States. JAMA 1982; 247: 987-97.

https://doi.org/10.1001/jama.1982.03320320023024

Hellier J. Goldstein H. The use of birth weight and gestation to assess perinatal mortality risk. J Epidemiol Community Health 1979; 33: 183-85. https://doi.org/10.1136/jech.33.3.183

Schwarcs R, Díaz AG, Fescina R et al. Epidemiología del bajo peso al nacer en maternidades de América Latina. Publicación Científica 915, CLAP, OPS/OMS, Montevideo, 1981.

Cifuentes R, Ortiz I, Martínez D. Aspectos perinatales del bajo peso al nacer en Cali, Colombia. Rev. Latinoam Perinatol 1987; 7: 11-5.

Herrera JA, Moreno CH. Comportamiento gráfico de la presión arterial diastólica durante el embarazo en gestantes con riesgo de preeclampsia. Colombia Med 2000; 31:4, 131-4.

Xiong X, Buekens P, Vastardis S, Yu SM. Periodontal disease and pregnancy outcome: state-of-the science. Obstet Gynecol Surv 2007; 62 (9):605-15. https://doi.org/10.1097/01.ogx.0000279292.63435.40

Hermida RC, Ayala DE, Iglesias M. Predictable blood pressure variability in healthy and complicated pregnancies. Hypertension 2001; 38(3): 736-41. https://doi.org/10.1161/01.HYP.38.3.736

Zhang J, Villar J, Sun W, MerialdI M, Abdel-Aleem H, Mathai M et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2007; 197(2):162-6. https://doi.org/10.1016/j.ajog.2007.03.053

Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007 166(11): 1312-9.

Pitiphat BW, Joshipura KJ, Rich-Edwards JW, Williams PL, Douglass CW, Gillman MW. Periodontitis and plasma c reactive protein. J periodontol 2006; 77 (5): 821-5. https://doi.org/10.1902/jop.2006.050193

Herrera JA, Parra B, Herrera E, Arce R, López- Jaramillo P, Contreras A. Periodontal disease severity is related to high levels of C-reactive protein in preeclampsia. J Hypert 2007 25(7):1459-1464. https://doi.org/10.1097/HJH.0b013e3281139ea9

Herrera JA, Hurtado H, Cáceres D. Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391-9.

Herrera JA, Salmerón B, Hurtado H The biopsychosocial risk asessment and the low birthweight. Soc Sci Med 1997; 44: 1107-14. https://doi.org/10.1016/S0277-9536(96)00240-7

Zuspan FF, Cibils LA, Pose SV. Myometrial and cardiovascular responses to alterations in plasma epinephrine and norepinephrine. Am J Obstet Gynecol 1962; 84: 841-51. Parto prematuro: enfermedad trazadora de bajo peso al nacer y mortalidad perinatal 72 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia.

Herrera JA. Alvarado JP, Martínez JE. The psychosocial environment and the cellular immunity in the pregnant patient. Stress Med 1988; 4: 49-57. https://doi.org/10.1002/smi.2460040109

Mancuso R, Dunkell Sc, Rini CM, Roesch SC, Hobel CJ. Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery. Psychosom Med 2004 ; 66:762-9. https://doi.org/10.1097/01.psy.0000138284.70670.d5

Kazy Z, Puhó E, Czeizel E. The posible effect of ampicillin treatment in preventing preterm delivery. Orv Hetil 2007; 148(30):1421-6. https://doi.org/10.1556/oh.2007.28023

Nelson D, Bellamy S, Nachamkin I, Ruffin A, Allen-Taylor L, Friedenberg FK. Characteristics and Pregnancy Outcomes of Pregnant Women Asymptomatic for Bacterial Vaginosis. Matern Child Health J 2007, 12 (2): 216-22.

https://doi.org/10.1007/s10995-007-0239-7

Majenory BA, Ukkadam S. Screening and treatment for sexually transmitted infections in pregnancy. Am Fam Physician 2007; 76(2):272.

O'brien RF. Bacterial Vaginosis: many questions - any answers? Curr Opin Pediatr 2005 17 (4): 473 - 9.

https://doi.org/10.1097/01.mop.0000170516.35272.45

Kousmans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in non pregnant and pregnant women: a synthesis of data. Clin Infect Dis 2002; 35 (S2):S 152-72.

Brunham RC, Paavonen J, Stevens CE et al. Mucopurulent cevicitis -the ignored counterpart in women of urethritis in men. New Engl J Med 1984; 311: 1-6. https://doi.org/10.1056/NEJM198407053110101

Nettleman MD, Jones RB, Roberts SD et al. Cost efectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases. Ann Intern Med 1986; 105: 189-96. https://doi.org/10.7326/0003-4819-105-2-189

Turrentine MA, Newton ER Amoxacilin or Erytromicin for the treatment of antenatal Chlamydial infection: A meta-analysis. Obstet Gynecol 1995; 86: 1021-5. https://doi.org/10.1016/0029-7844(95)00296-4

Larsson PG, Bergström M, Forsum U, Jacobson B, Strand A, Wölne-Hansen P. Bacterial vaginosis. Transmission. Role in genital tract infection and pregnancy outcome: an enigma. APMIS 2005; 113 (4):233-45.

https://doi.org/10.1111/j.1600-0463.2005.apm_01.x

Moore S, Ide M, Randhawa M, Walker JJ, Reid JG, Simpson NA. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG 2004; 11(2): 125-32.

https://doi.org/10.1046/j.1471-0528.2003.00024.x-i1

Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006; 194 (5): 1234-42.

https://doi.org/10.1016/j.ajog.2005.06.049

Rebarber A, Istwan NB, Russo-Stieglitz K, Claery-Goldman J, Rhea DJ, Stanziano GJ et al. Increased incidence of gestational diabetes in women receiving prophylactic 17 alpha-hidroxyprogesterone caproato for prevention of recurrent preterm delivery. Diabetes care 2007; 30 (9): 2277-80. 73. https://doi.org/10.2337/dc07-0564

Mercer BM, Goldenberg RL, Das A, Moawad AH, Iams JD, Meis PJ et al. The preterm prediction study: A clinical risk system. Am J obstet Gynecol 1996; 174 (6) : 1893-5. https://doi.org/10.1016/S0002-9378(96)70225-9

Dijkstra K, Janssen HC, Kuczynski E, Lockwood CJ. Cervical lenght in uncomplicated pregnancy: A study of sociodemographic predictors of cervical changes across gestation. Am J Obstet Gynecol 1999; 180 (3 P1): 639-44.

https://doi.org/10.1016/S0002-9378(99)70267-X

Vaissière C, FavreR, Audibert F, Chauvet MP, Gaucherand P, Tradif D et al. Cervical assessment at 22 and 27 weeks for the prediction of spontaneous birth before 34 weeks in twin pregnancies: is transvaginal sonography more accurate than digital examination? Ultasound Obstet Gynecol 2005; 26 (7): 707-12. https://doi.org/10.1002/uog.2616

Madarek EO, Najati N. The effect of glucocorticoid therapy in preventing early neonatal complications in preterm delivery. J Perinat Med 2003; 31(5): 441-3. https://doi.org/10.1515/JPM.2003.069

CAPÍTULO 4:

Damm P, Breitowicz B, Hegaard H. Exercise, pregnancy, and insulin sensitivity-what is new?. Appl Physiol Nutr Metab 2007; 32 (3): 537-40. https://doi.org/10.1139/H07-027

Kalhan SC, D'Angelo L.J, Sanin SM et al. Glucose production in pregnant women at term gestation. J Clin Invest 1979; 63:388. https://doi.org/10.1172/JCI109314

Felig P. Body fuel metabolism and diabetes mellitus in pregnancy. Med Clin North Am 1977; 61:43. https://doi.org/10.1016/S0025-7125(16)31348-7

Page EW. Human fetal nutrition and growth. Am J Obstet Gynecol 1969; 104:378. https://doi.org/10.1016/S0002-9378(16)34190-4

Adams PA, Terramo K. Raiha N. Human fetal insulin metabolism early in gestation. Diabetes 1969, 18: 409.

https://doi.org/10.2337/diab.18.6.409

Obenshain SS, Adam PA, King KC et al. Human fetal insulin response to sustained maternal hyperglycemia. N Engl J Med 1970; 283: 566. https://doi.org/10.1056/NEJM197009102831104

Tyson JE, Barnes AC, Meminee TJ et al. Isolated growth hormone deficiency. Studies in pregnancy. J Clin Endocrinol Metab 1970; 31:147.

Spellacy WN, Goetz FC. Plasma insulin in normal late pregnancy. N Engl J Med 1963; 268: 988. https://doi.org/10.1056/NEJM196305022681805

Soler NG, Soler SM, Nalin JM. Neonatal morbidity among infants of diabetic mothers. Diabetes Care 1978, 1: 340.

https://doi.org/10.2337/diacare.1.6.340

Sepe SJ, Conell FA, Geiss LS et al. Gestational diabetes incidence, maternal characteristics and perinatal outcome. Diabetes 1985; 34 (suppl2): 13. https://doi.org/10.2337/diab.34.2.S13

Jacobson JD, Cousin LA. A population-based study of maternal and perinatal outcome in patient with gestational diabetes. Am J Obstet Gynecol 1989; 161: 981. https://doi.org/10.1016/0002-9378(89)90767-9

Montor MN, Myers VP, Mestman JH et al. Outcome of pregnancy in diabetes ketoacidosis. Am J Perinatol 1993, 10:17. https://doi.org/10.1055/s-2007-994692

Willman SP, Leveno KJ, Guzick DS et al. Glucose threshold to macrosomia in pregnant complicated by diabetes. Am J Obstest Gynecol 1986; 154: 470. https://doi.org/10.1016/0002-9378(86)90692-7

Menon RK, Cohen RM, Sperling MA et al. Transplacental passage of insulin in pregnant women with insulin dependent diabetes mellitus. N Engl J Med 1990: 323: 309. https://doi.org/10.1056/NEJM199008023230505

Fuhrmann K Reiher H, Semmier K et al. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983; 6: 219. https://doi.org/10.2337/diacare.6.3.219

Richardson AC, Carpenter MW. Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Sm 2007; 34 (2): 213-24. https://doi.org/10.1016/j.ogc.2007.04.001

Karlson K, Kjellmer Y. The outcome of diabetic pregnancy in relation to the mother blood sugar levels. Am J Obstet Gynecol 1972, 112:13. Diabetes mellitus gestacional: enfermedad trazadora de mortalidad perinatal 82 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia.

Jovanovics C, Druzin M, Peterson C. Effects of euglycemia on the outcome of pregnancy in insulin dependent diabetic women as compared whith normal control subjects. Am J Med 1981; 71: 921. https://doi.org/10.1016/0002-9343(81)90301-6

Ogonowsky J, Miazgowsky T, Homa K, Celewics Z, Kuczinska M. Low predictive value of traditional risk factors in identifying women at risk for gestational diabetes. Acta Obstet Gynecol Scand 2007; 2:1-6. https://doi.org/10.1080/00016340701505044

Kitzmiller JL. Cloherty JP, Younger MD. Diabetes Pregnancy and perinatal morbidity. Am J Obstet Gynecol 1978; 1131:560. https://doi.org/10.1016/0002-9378(78)90120-5

Gómez G, Rebolledo AM, Restrepo CE. Morbimortalidad fetal por diabetes en la clínica de embarazo de alto riesgo del Hospital Universitario del Valle, Cali Colombia. Colombia Med 1991; 22:144.

Herrera JA, Erscheng G, Shahabuddin AKM et al. Riesgo biopsicosocial en la predicción de las complicaciones maternas y perinatales en países asiáticos 2002-2003. Colombia Med 2006, 37 (1S): 1-8.

O'Sullivan JB, Mahan CM, Charles D et al. Screening criteria for high - risk gestational diabetic patients. Am J Obstet Gynecol 1973; 116:895. https://doi.org/10.1016/S0002-9378(16)33833-9

O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13:278.

https://doi.org/10.2337/diab.13.6.572

Johnston-MacAnanny EB, Ness A, Weinstein L. Diagnosis of gestational diabetes mellitus: is it time for a new critical value? J Reprod Med 2007; 52 (6):463-6

Cousin L, Baxi L, Chez R et al. Screening recomendations for gestational diabetes mellitus. Am J Obstet Gynecol 1991; 165:493. https://doi.org/10.1016/0002-9378(91)90273-T

CAPÍTULO 5:

Queenan JT. Erythroblastosis fetalis. En: Queenan JT (ed). Management of high risk pregnancy. Medical Economies 1980. Uradell.

Sanson D, Mollinson PI. Effect on primary Rh-immunization of delayed administration of anti-Rh. Immunology 1975; 28:349.

Zypursky Y, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J 1967; 97:1245.

https://doi.org/10.1007/978-94-011-6138-1_40

Boloman JM. Suppresion of Rh isoimmunization. Obstet Gynecol 1978; 52: 385.

Zipursky A. Rh hemolitic disease of the newborn. The disease erradicated immunology Clin Obstet Gynecol 1977; 20: 759. https://doi.org/10.1097/00003081-197709000-00021

Hytten F. Blood volume changes in normal pregnancy. Clin Haematol 1985;14: 601. https://doi.org/10.1016/S0308-2261(21)00496-3

Masson PL., Delire M. Cambiasso CL. Circulating immune complexes in normal human pregnancy. Nature 1977; 266: 542. https://doi.org/10.1038/266542a0

Delleuw NK, Lowenstein L., Hsieh YS. Iron deficiency and hydremia in normal pregnancy. Medicine 1966; 45: 291.

https://doi.org/10.1097/00005792-196607000-00002

Garn SM, Keating MT, Falkner F. Hematological status and pregnancy outcome. Am J Clin Nutr 1981; 34: 115.

Milman N. Iron prophylaxis in pregnancy-general or individual and in which dose? Ann Hematl 2006; 85 (12);821-8. https://doi.org/10.1007/s00277-006-0145-x

Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol. 2002 ;187(2):412-8. https://doi.org/10.1067/mob.2002.123895

Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005 May;81(5):1218S-1222S.

Rehman A, Collis CS, Yang M, Kelly M, Diplock AT, Halliwell B et al. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers.Biochem Biophys Res Commun 1998 ;246(1):293-8. https://doi.org/10.1006/bbrc.1998.8592

Vaughan JE, Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypert pregnancy 2002; 21(3):205-23. https://doi.org/10.1081/PRG-120015848

Branch DW, Andres R, Digre KB. The association of antiphospholipid antibodies whith severe preeclampsia. Obstet Gynecol 1989; 73: 541.

Little PJ. The incidence of urinary infection in 5000 pregnant women. Lancet 1966; 470: 925. https://doi.org/10.1016/S0140-6736(66)90534-4

Hootton TM, The epidemiology of urinary tract infection and the concept of significant bacteriuria. Infection 1990; 18 (Suppl 2): S40-3. 93. https://doi.org/10.1007/BF01643424

Turck M, Goffe BS, Petersdorf RG. Bacteriuria of pregnancy: relation to socieconomic factors. Engl J Med 1962; 266:857. https://doi.org/10.1056/NEJM196204262661703

Harris RE, Thomas VI, Shelokov A. Asymptomatic bacteriuria in pregnancy: antibodyocoated bacteria, renal function and intrauterine growth retardation. Am J Obstet Gynecol 1976; 126:20. https://doi.org/10.1016/0002-9378(76)90458-0

Kass H. Progress in pyelonephritis. FA Davis Co., Philadelphia 1965.

Lindheimeir MD, Katz Al. Renal function and disease in pregnancy. Lea & Febiger, Philadelphia, 1977.

Kincaid- Smith P. Bacteriruria and urinary infection in pregnancy. Clin Obstet Gynecol 1972; 11: 533.

Beard RW, Roberts AP. Asymptomatic bacteriuria during pregnancy. Br Med Bull 1968; 24: 44.

Cheslley IC. Hypertensive disorders in pregnancy. Apleton Century Crofts. New York. 1978.

Walley PJ. Bacteriuria of pregnancy. Am J Obstet Gynecol 1967; 97: 723. https://doi.org/10.1016/0002-9378(67)90458-9

Lyndheimer LD Katz LA. The kidney brenner and Rector. 3rd ed. 1986, pp1269.

Golan A, Wexler S, Amit A et al. Asymptomatic bacteriuria in normal and high- risk pregnancy. Eur J Obstet Gynecol Repr. Biol 1989; 33:101. https://doi.org/10.1016/0028-2243(89)90202-5

Kincaid- Smith PS, Failey KF. The kidney and hypertension in pregnancy. Churchill Livingstone, 5st ed. 1973.

Sweet RL, Gibbs RS. Infectious diseases of the female genital tract. 2nd. ed. Baltimore Wiliams & Wilkins, pp 267, 1990.

Lenke RR, Van Dorsten JP. The efficacy of the nitrite test and microscopic urianalysis in predicting urine culture results. Am J Obstet Gynecol 1981; 140:427. https://doi.org/10.1016/0002-9378(81)90039-9

Zimmer SH, Kass EH. Long term (10 to 14 years) follow-up of bacteriuria of pregnancy. N Engl J Med 1971; 111: 441.

Abyad A. Screening for asymptomatic bacteriuria in pregnancy: urianalysis vs. urine culture. J Fam Pract 1991; 33: 471.

CAPÍTULO 6:

Herrera JA & Hurtado H, Cáceres D. Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391-399.

Coussons-Read ME, Okun ML, Scmitt MP, Giese S. Prenatal stress alters cytokine levels in a manner that may endanger human pregnancy. Psychosom Med 2005; 67 (4):625-31. https://doi.org/10.1097/01.psy.0000170331.74960.ad

Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflamatory markers and alters cytokine production across pregnancy. Brain Behav Imm 2007; 21(3):343-50. https://doi.org/10.1016/j.bbi.2006.08.006

Herrera JA & Hurtado H, Cáceres D. Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391-399.

Herrera JA, Alvarado JP & Restrepo W. Riesgo biopsicosocial prenatal y preeclampsia. Atenc Primaria 1995; 16:9,552-55.

Herrera JA Salmerón B., Hurtado H. The biopsychosocial risk assessment and the low birthweight. Soc Sci Med 1997; 44:8, 1107-14. Justificación teórica del riesgo psicosocial asociado a las complicaciones perinatales 104 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia

Herrera JA, Erscheng G, Shahabuddin AKM et al. Riesgo biopsicosocial en la predicción de las complicaciones maternas y perinatales en países asiáticos 2002-2003. Colombia Med 2006, 37 (1S): 1-8.

Takiuti NH, Kahhale S, Zugaib M. Stress in pregnancy: a new Wistar rat model for human preeclampsia. Am J Obstet Gynecol 2002; 186 (3):544-50. https://doi.org/10.1067/mob.2002.121102

Salvatierra V. Psicobiología del embarazo y sus transtornos. Barcelona. Martínez Roca 1989.

Valdés M, Florés T. Psicobiología del estrés, Barcelona , Martínez Roca, 1985.

Donovan BT. Humors, hormones and the mind. Basingstoke. Scockton Press, 1988. https://doi.org/10.1007/978-1-349-19025-6

Holt V. Beta-endorphin in human plasma, basal and pathologically elevated levels. Life Sci 1979; 25: 37-44.

https://doi.org/10.1016/0024-3205(79)90487-9

Shabanah EH, Thoth AY, Maughan GB. The role of the autonomous nervous system in uterine contractility and blood flow. 1. The interaction between neurohormones and sex steroids in the intact and isolates uterus II. The role of the parasympathetic neurohormone acetylcholine in uterine motility and blood flow. Am J Obstet Gynecol 1964; 89: 841-59; 860-80. https://doi.org/10.1016/0002-9378(64)90055-9

Vuquin PM. Animal models for small for gestational age and fetal programming of adult disease. Horm Res 2007; 68(3): 113-23. https://doi.org/10.1159/000100545

Zuspan FF, Cibils LA, Pose SV. Myometrial and cardiovascular responses to alterations in plasma epinephrine and norepinephrine. Am J Obstet Gynecol 1962; 89: 841-51. https://doi.org/10.1016/0002-9378(62)90057-1

Myers RE. Maternal psychological stress and fetal asphyxia: a study in the monkey. Am J Obstet Gynecol 1975; 122: 47-51. https://doi.org/10.1016/0002-9378(75)90614-6

Lazarus LS. Folkman S. Estrés y procesos cognitivos. Barcelona, Martínez Roca, 1984.

Mason JW. A review of psychoendocrine research on the pituitary-adrenocortical system. Psychosom Med 1968; 30: 576-607. https://doi.org/10.1097/00006842-196809000-00020

Schaefer C, Coyne JC, Lazarus RS. The health related functions of social support. J Behav Med 1982; 4; 381-406.

https://doi.org/10.1007/BF00846149

Bloom T, Curry MA, Durham L. Abuse and psychosocial stress as factors in high utilization of medical services during pregnancy. Issues Ment Health Nurs 2007;28(8):849-66. https://doi.org/10.1080/01612840701493212

CAPÍTULO 7:

Bayés, R. y Borras, F. X. (1999). Psiconeuroinmunología y salud. En Simon M. G., Manual de Psicología de la Salud: Fundamentos metodologías y aplicaciones. Universidad Autónoma de Madrid.

Crespo M, Labrador FJ. (2001) Evaluación y Tratamiento del Estrés. Revista Psicología y salud: control del estrés y conductas de riesgo; 57: 104.

Lazarus, R.S. (2000). Estrés y emoción: manejo e implicaciones en nuestra salud. Bilbao. Editorial Desclée de Brouwer, S.A.

CAPÍTULO 8:

Sosa R, Kennell J, Klaus M, Robertson S, Urrutia J. The effect of a supoportive companion on perinatal problems, lenght of labor, and mother-infant interaction. N Engl J Med. 1980 Sep 11;303(11):597-600.

https://doi.org/10.1056/NEJM198009113031101

Herrera JA, Hurtado H, Cáceres D., Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391 - 99.

CAPÍTULO 9:

Metcalfe J, Stock M, Barron D. Maternal physiology during gestation. In: Knobil E, Neill J, editors. The physiology of reproduction. New York: Raven Press; 1988.p. 2145-76.

RM, Pikin and WN ,Spellacy. Physiologic adjustment in general. In: laboratory Indices of Nutritional Status in Pregnancy (Committee on Nutrition of the Mother and Preschool Child, Food and Nutrition Board, National Research Council) pp 1-8 National Academy of Sciences, Washington DC.

Hytten F, Chamberlain G. Clinical physiology in obstetrics. Oxford, Blackwell Sc. Publ, 1980.

WHO. Maternal anthropometry and pregnancy outcomes. A WHO Collaborative Study. Supplement to Vol. 73, Geneva 1995.

Herrera J, Cáceres Delcy, Gracia Beatriz. en libro Aplicación de un Modelo Biopsicosocial para la reducción de la morbilidad y Mortalidad Materna y perinatal en Colombia. Cap. VIII, Atención Nutricional a la Gestante. 2da Ed 2001.

Food and Nutrition Board. Institute of Medicine: Dietary Reference intakes for vitamin C, vitamin E, selenium and carotenoids. Washington, DC: National Academy of Science, 2000.

FAO/OMS/UNU. 1995. Necesidades de Energía y de Proteínas. Serie Inf. Técn 724. OMS, Ginebra 1985.

Food and nutrition board: recommended dietary allowances. 10th rev. ed. Washington, DC: National Academy of Sciences 1989.

Instituto Colombiano de Bienestar familiar. Recomendaciones de consumo diario de Calorías y Nutrientes para la Población Colombiana. ICBF Ed, 2000.

Turner R. Nutrition during Pregnancy. In: Modern Nutrition in Health and Disease. Shils M, Shike M, Ross A,Caballero B, Cousins R, editors, Tenth Edition, Lippincott Williams & Wilkins, Baltimore. 2006. Pp 771-78.

Bloch A and Shils M. Appendices, Section II. National and International Recommended Dietary Reference values. In: Modern Nutrition in Health and Disease.Shils M, Shike M, Ross A, Caballero B, Cousins R, editors, Tenth Edition, Lippincott Williams & Wilkins, Baltimore. 2006. Pp 1852-1900.

Taffel SM. Maternal weight gain and the outcome of pregnancy. United States: National Center for Health Statistics 1986; series 21, 44-47.

Taffel SM, Keppel KG. Implications of mothers weight gain and the outcome of pregnancy. Proceedings of the Social Statistics Section of the American Statistical Association. Washinton, DC. 1984; 238-9. 177

Abrams B. Weight gain and energy intake during pregnancy. Clinical Obstetrics and Ginecology 1994; 37(3):515-527. https://doi.org/10.1097/00003081-199409000-00005

Institute of Medicine. Subcommittee on Nutritional Status and Weight Gain During Pregnancy. Nutrition during pregnancy: weight gain and nutrient supplements. Washington, DC: National Academy Press 1990; Part I: 27-233.

F.E Hytten (1980) Weight gain in pregnancy. In: Clinical Physiology in Obstetrics (F.E Hytten and G. Chamberlain, eds) pp 193-233, Blackwell, Oxford.

Conway R, Reddy S, Davies J. Dietary restraint and weight gain during pregnancy. Eur J Clin Nut 1999;5: 849-853.

https://doi.org/10.1038/sj.ejcn.1600864

Poston L, Briley Al, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebocontrolled trial. Lancet 2006; 367 (9517):1145-54. https://doi.org/10.1016/S0140-6736(06)68433-X

Scholl TO, Hediger ML, Scholl JI, Khoo CS and Fischer RL. Maternal growth during pregnancy and the competition for nutrients. Am J Clin Nutr 1994; 60:183-188, 1994. h

Dodds L, Fell DB, Dooley KC, Armson BA, Allen AC, Nassar BA et al. Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin Chem 2008 54:326-34.

https://doi.org/10.1373/clinchem.2007.097469

Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008 198:45-7.

Rosso P. Farmacoterapia y Embarazo. Nuevas recomendaciones nutricionales para el embarazo. Rev Actual Ginecol Obstet 1991;4(5):351.

Ziegler E, Filer L. Conocimientos Actuales sobre Nutrición. Séptima edición. 1997. https://doi.org/10.1590/S1135-57271998000400011

Heinze T, Weber W. Determination of thiamine (vitamin B1) in maternal blood during normal pregnancies and pregnancies with intrauterine growth retardation. Z Ernahrungswiss 1990; 29:39-46. https://doi.org/10.1007/BF02019533

American Academy of Pediatrics and America College of Obstetricians and Gynecologists. Guidelines for Prenatal Care 1983.

Centers for Disease Control and Prevention. Pregnancy nutrition surveillance. U.S. Departament of Health and Human Services 1996.

Rosso P. Desnutrición materna y retardo del crecimiento fetal. Avances en la compresión de sus mecanismos. Bol Esc Med 1993;85-9.

Mora JO, Mora OL. Deficiencia de Nutrientes en América Latina y el Caribe. Anemia ferropriva. Caracas: Fundación Cavendes 1997.p. 1-4.

Instituto Colombiano de Bienestar Familiar. Encuesta Nacional de la situación nutricional en Colombia. ENSIN- 2005. Atención nutricional a la mujer gestante 178 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia.

Tamura T, Goldenberg R, Johnston K, DuBard M. Maternal plasma zinc concentrations and pregnancy outcome. Am J Clin Nut 2000; 71 (1):109-13.

King J. Determinants of maternal zinc status during pregnancy. Am J Clin Nut 2000; 71Suppl:1334-43.

Hambidge KM, Krebs NF, Jacobs MA, Favier A, Guyette L, Ikle DN. Zinc nutritional status during pregnancy: a longitudinal study. Am J Clin Nutr 1983; 37:429-42.

Berg JM and others: Biochemistry, 5yh ed. New York: W.H. Freeman and Company, 2002.

Repke JT. Calcium and Vitamin D. Clinical Obstetrics and Ginecology 1994; 37(3):550-557. https://doi.org/10.1097/00003081-199409000-00008

Herrera MG. Deficiencia de vitamina A: Prevención y tratamiento. Sem Int Gastroenterol Nutr Pediatr 1995; 4 (4): 3 - 8.

Azais-Braesco V. and Pascal G. Vitamin A in pregnancy: requirements and safety limits. Am J Clin Nutr 2000: 71: 1325S-33S.

Brownline T and others: Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Cl Nutr. 75:734,2002.

YIP R: Iron. In Bowman BA, Russell RM (eds): Present knowledge in nutrition. 8th Edition. Washington DC: International Life Sciences Institute, 2001.

Schumann K: safety aspects of iron in food. Annals of Nutrition and Metabolism 45:91. 2001. https://doi.org/10.1159/000046713

Allen H. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000; 71: 1280S-4S.

Thwell T. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000; 72: 257S-64S.

Lynch SR. The potential impact of iron supplementation during adolescence on iron status in pregnancy. J Nutr 2000; 130:448S-451S.

Scholl T and Jonson W. Folic Acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000; 71: 1295S-303S.

Prentice A. Maternal calcium metabolism and mineral status. Am J Clin Nutr 2000; 71: 1312S - 6.

J. Villar and JM, Belizan. Calcium during pregnancy. Clin Nutr. 5:55-62, 1986. 46. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for Prenatal Care 1983.

Centers for Disease Control and Prevention. Pregnancy nutrition surveillance. U.S. Departament of Health and Human Services 1996. 179

Shabert J. Nutrition during Pregnancy and Lactation. In: Krause's Food, Nutrition, & Diet Therapy. Mahan L and Escott-Stump S, editors, 11 th Edition, Elsevier, USA. 2004. Pp 182-201.

De Vriese S, De Henauw S, De Backer G, Dhont M. Estimation of dietary fat intake of Belgian pregnant women. Ann Nutr Metab 2001; 45:273-8. https://doi.org/10.1159/000046738

González F, Brito M, Maneiro P. El embarazo en adolescentes: un problema de alto riesgo obstétrico. Rev Obstet Ginecol Venez 1997;57 (1):13-17.

Marcano M, Marbella J, Solano L, Meertens L. Riesgo nutricional en el último trimestre del embarazo según consumo de energía y nutrientes. Rev Salud 2000;4(3): 1-12.

Pérez J, Sánchez M, Reig A, Peñate, M, Estévez M, Escoto F y López R. Ingesta dietética y estado de nutrición del hierro en embarazadas según índice de masa corporal. Rev Cub Aliment Nutr 2000; 14(1):33-8.

Mathews F, Yudkin P, Neil A. Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ 1999; 319:339-43. https://doi.org/10.1136/bmj.319.7206.339

Concepción Santos de León, Gladys Henriquez Pérez, Ingrid Rached de Paoli, Arelis Azuaje Sánchez. Adecuación de nutrientes en gestantes y su relación con el peso del recién nacido. Ann Venez. Nutr, V.16, No2. Caracas, Jun 2003.

Instituto Colombiano de Bienestar Familiar. Guías Alimentarias para gestantes y madres en lactancia. Bases Técnicas, Bogotá D.C Colombia 2004.

Instituto Colombiano de Bienestar Familiar. Guías Alimentarias para gestantes y madres en lactancia. Caracterización de la Población, Bogotá D.C Colombia 2004.

CAPÍTULO 10:

Beynon HL, Davies KA, Walport MJ. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium. J Immunol 1994; 153 (7): 3160-7.

Dramochwall-Kolarz D, Saito S, Rolinsky J, Tabarckiewics J, Kollars B et al. Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 2007; 58 (1): 39-45. https://doi.org/10.1111/j.1600-0897.2007.00489.x

Milman N. Iron and pregnancy a delicate balance. Ann Hematol 2006; 85:559-65. https://doi.org/10.1007/s00277-006-0108-2

Basher K, Deb K. Alteration in iron status in preeclmpsia. Mymensingh Med J 2006; 15 :22-4.

Lyann F. Priming and remodelling of human placental bed spiral arteries during pregnancy- a review. Placenta 2005; 26:S31-6. https://doi.org/10.1016/j.placenta.2005.02.010

Wheller T, Sollero C, Alderman S, Landen J, Anthony F, Osmond C. Relation between maternal haemoglobin and placental hormona concentration in early pregnancy. Lancet 1994; 343:511-13. https://doi.org/10.1016/S0140-6736(94)91461-3

Perry I, Beepers B, Whincup P, Bareford D. Predictors of ratio of placental weight to fetal weight in multiethnic community. BMJ 1995;310:436-39. https://doi.org/10.1136/bmj.310.6977.436

Kadyrov M, Scmitz C, Black S, Kaufmann P, Huppertz B. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 2003; 24:540-8.

https://doi.org/10.1053/plac.2002.0946

Duesterberg CK, Cooper WJ, Waite D. Fenton-mediated oxidation in the presence and absence of oxygen. Environ Sci Technol 2005; 39:5052-8. https://doi.org/10.1021/es048378a

Dendford A, Heidbreder M, Hellwing-Burgel T, Johren O, Qadry F, Dominiak P. Deferoxamine induces prolongad cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med 2005; 38:117-24.

https://doi.org/10.1016/j.freeradbiomed.2004.10.015

Freeman M, Crapo J. Hypoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256:10986-92. https://doi.org/10.1016/S0021-9258(19)68544-3

Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tirante V, Zeviani M et al. Oxygen sensing requires mityochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1:409-14. https://doi.org/10.1016/j.cmet.2005.05.002

Watson AL, Skee'Per JN, Jauniaux E, Burton GJ. Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab 1998; 83:1697-705.

https://doi.org/10.1210/jc.83.5.1697

O Scholl T. Iron status during pregnancy: setting the stage for the mother and infant. Am J Clin Nutr. 2005 81(5):1218S-1222S. https://doi.org/10.1093/ajcn/81.5.1218

ayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol. 2002;187(2):412-8. 189. https://doi.org/10.1067/mob.2002.123895

Escudero C, Calle A. Iron, oxygen and placental development in the etiology of preeclampsia. Effects of high altitude in Ecuador. Rev Med Chil 2006; 134:491-8. https://doi.org/10.4067/S0034-98872006000400014

School TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr 1994; 59:492S-501S.

Scanlon KS, Yip R, Schieve LA, Cogswell ME. High and low hemoglobin levels during pregnancy:differential risks for preterm birth and small for gestational age. Obstet Gynecol 200;96:741-8. https://doi.org/10.1016/S0029-7844(00)00982-0

Allen LH. Biological mechanisms that might underline iron's effect on fetal growth and preterm birth. J Nutr 2001; 131:581S-9S.

Cogswell ME, Parvanta I, Ickes L, Yip R, Brittenham. Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. M J Clin Nutr 2003;78:1194-1202.

Christian P, West Jr KP, Khatry SK et al. Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal. Am J Clin Nutr 2003;78:1194-1202.

Zhou LM, Yang WW, Hua JZ, Deng CQ, Tao X, Stolzfus RJ. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. Am J Epidemiol 1998;148:998-1006.

Goldenberg RL, Tamura T, DuBard M, Johnston KE, Copper RL, Negrees Y. Plasma ferritin and pregnancy outcome. Am J Obstet Gynecol 1996;175:1356-9. https://doi.org/10.1016/S0002-9378(96)70054-6

Scholl TO. High third-trimester ferritin concentration: associations with very preterm delivery, infection, and maternal nutritional status. Obstet Gynecol 1998;92:161-5. https://doi.org/10.1097/00006250-199808000-00001

Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr 2003; 133:1700S-8.

Fernández-Real JM, López-Bermejo A, Ricart W. Croos-talk between iron metabolism and diabetes. Diabetes 2002; 51:2348-54. https://doi.org/10.2337/diabetes.51.8.2348

Keyes LE, Armaza JF, Niermeyer S, Vargas E, Young DA, Moore LG. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res 2003; 54:20-5. https://doi.org/10.1203/01.PDR.0000069846.64389.DC

Palmer SK, Moore LG, Young D, Cregger B, Berman JA, Zamudio S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3.100 meters) in Colorado. M J Obstet Gynecol 1999; 180: 1161-8. https://doi.org/10.1016/S0002-9378(99)70611-3

Soleymanlou N, Jurisica I, Nevo O, ITEA F, Zhang X, Zamudio S et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 2005; 90:4299-308.

Askew EW. Work at high altitude and oxidative stress:antioxidant nutrients. Toxicology 2002; 180:107-19. Suplemento de hierro en el embarazo 190 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia.

Tam WH, Sahota DS, Lau TK, Li CY, Fung TY. Seasonal variation in pre-eclamptic rate and its association with the ambient temperature and humidity in early pregnancy. Gynecol Obstet Invest. 2008; 66(1):22-26.

https://doi.org/10.1159/000114252

Takiuti NH, Kahhale S, Zugaib M. Stress in pregnancy: a new Wistar rat model for human preeclampsia. Am J Obstet Gynecol 2002; 186 (3):544-50. https://doi.org/10.1067/mob.2002.121102

Weigel M, Narváez M, Félix C, López A, López-Jaramillo P. Prenatal diet, nutrient intake and pregnancy outcome in urban Ecuadorian primiparas. Arch Latinoam Nutr 1991; 41:21.

CAPÍTULO 11:

Herrera JA, Chaudhuri G., C, López-Jaramillo P. Is infection a major risk to preeclampsia? Hypoth Med 2001; 57: 3, 393-7. https://doi.org/10.1054/mehy.2001.1378

Herrera JA, Alvarado JP & Martinez JE. The psychosocial environment and the cellular immunity in the pregnant patient. Stress Med 1988; 4: 49-57. https://doi.org/10.1002/smi.2460040109

Herrera JA, Shahabuddin AKM, Ersheng G , Wei Y, García R, López- Jaramillo P. Calcium plus linoleic acid therapy for pregnancy-induced hypertension. Int J Obstet Gynecol 2005. 91: 221-227. https://doi.org/10.1016/j.ijgo.2005.08.018

Herrera JA, Arevalo-Herrera M, Shahabuddin AKM, Ersheng G , Herrera S, Garcia R, López- Jaramillo P. Calcium and conjugated linoleic acid reduces pregnancyinduced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypert 2006; 19:381-87. https://doi.org/10.1016/j.amjhyper.2005.11.004

Herrera JA Salmerón B., Hurtado H. The biopsychosocial risk assessment and the low birthweight. Soc Sci Med 1997; 44:8, 1107-14. https://doi.org/10.1016/S0277-9536(96)00240-7

Herrera JA, Alvarado JP & Restrepo W. Riesgo biopsicosocial prenatal y preeclampsia. Atenc Primaria1995;16:9,552-55.

Herrera JA, Erscheng G, Shahabuddin AKM et al. Riesgo biopsicosocial en la predicción de las complicaciones maternas y perinatales en países asiáticos 2002-2003. Colombia Med 2006, 37 (1S): 1-8.

Herrera JA, López- Jaramillo P, Shahabuddin AKM, Faisal M, Ersheng G, Wei Y et al. Efectos de la suplementación oral con calcio y ácido linoleico conjugado en primigravidas de alto riesgo. Colombia Med 2004; 35:1, 31-37.

CAPÍTULO 12:

Pinard A. Gingivitis in pregnancy. Dent Register 1877;31:258-259.

Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a posible risk factor for preterm low birthweight. J Periodontol 1996;67(10 Suppl):1103-1113.

López NJ, Smith PC, Gutierrez J. Periodontal therapy may reduce the risk of preterm low birth weight in women with periodontal disease: a randomized controlled trial. J Periodontol. 2002 ;73(8):911-24. https://doi.org/10.1902/jop.2002.73.8.911

Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111. https://doi.org/10.1111/j.1600-0757.1994.tb00020.x

Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2005;38:135- 187. https://doi.org/10.1111/j.1600-0757.2005.00107.x

Van Winkelhoff AJ, van Steenbergen TJ, de Graaff J. The role of black-pigmented Bacteroides in human oral infections. J Clin Periodontol 1988;15:145-155. https://doi.org/10.1111/j.1600-051X.1988.tb01561.x

Kadowaki T, Takii R, Yamatake K, Kawakubo T, Tsukuba T, Yamamoto K. A role for gingipains in cellular responses and bacterial survival in Porphyromonas gingivalis-infected cells. Front Biosci 2007;12:4800-4809. https://doi.org/10.2741/2428

Inagaki S, Kuramitsu HK, Sharma A. Contact-dependent regulation of a Tannerella forsythia virulence factor, BspA, in biofilms. FEMS Microbiol Lett 2005;249:291- 296.

Ebersole JL, Kraig E, Bauman G, Spitznagel JK, Kolodrubetz D. Molecular approaches to leucotoxin as a virulence component in Actinobacillus actinomycetemcomitans. Arch Oral Biol 1990;35 Suppl:69S-78S. 215 https://doi.org/10.1016/0003-9969(90)90133-U

Van Dyke T, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003;82:82-90. https://doi.org/10.1177/154405910308200202

Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249.

Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216-248.

https://doi.org/10.1111/j.1600-0757.1997.tb00199.x

Seymour GJ. Importance of the host response in the periodontium. J Clin Periodontol 1991;18:421-426.

https://doi.org/10.1111/j.1600-051X.1991.tb02310.x

Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res 1993;28:478-486. https://doi.org/10.1111/j.1600-0765.1993.tb02108.x

New insights into mechanisms of bacterial pathogenesis in periodontitis. Curr Opin Periodontol 1996;3:10-18.

Ishikawa I, Nakashima K, Koseki T, Nagasawa T, Watanabe H, Arakawa T, Nitta H, Nishihara T. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 20001997;14:79-111. https://doi.org/10.1111/j.1600-0757.1997.tb00193.x

Yamazaki K, Nakajima T, Gemmel E, Polar B, Seymour GJ, Hara K. IL-4 and IL6 producing cells in human periodontal disease tissue. J Oral Pathol Med 1994;23:347-353. https://doi.org/10.1111/j.1600-0714.1994.tb00074.x

Contreras A, Herrera JA, Soto JE, Arce RM, Jaramillo A, Botero JE. Periodontitis is associated with preeclampsia in pregnant women. J Periodontol 2006;77:182- 188. https://doi.org/10.1902/jop.2006.050020

Miranda LO, Guimaraes AN, Costa JE, Medeiros TC, Costa FO. Association Between Maternal Periodontitis and an Increased Risk of Preeclampsia. J Periodontol 2006;77:2063-2069. https://doi.org/10.1902/jop.2006.060061

Kunnen A, Blaauw J, van Doormaal JJ, van Pampus MG, van der Schans CP, Aarnoudse JG, van Winkelhoff AJ, Abbas F. Women with a recent history of earlyonset preeclampsia have a worse periodontal condition. J Clin Periodontol 2007; 34: 202-207. https://doi.org/10.1111/j.1600-051X.2006.01036.x

Oettinger-Barak O, Barak S, Ohel G, Oettinger M, Kreutzer H, Peled M, Machtei EE. Severe pregnancy complication (preeclampsia) is associated with greater periodontal destruction. J Periodontol. 2005 ;76(1):134-7. https://doi.org/10.1902/jop.2005.76.1.134

Romero BC, Chiquito CS, Elejalde LE, Bernardoni CB. Relationship between periodontal disease in pregnant women and the nutritional condition of their newborns. J Periodontol. 2002 ;73(10):1177-83. Relación entre enfermedad periodontal y las complicaciones durante el embarazo 216 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia.

Radnai M, Gorzó I, Nagy E, Urbán E, Novák T, Pál A. A possible association between preterm birth and early periodontitis. A pilot study. J Clin Periodontol. 2004 ;31(9):736-41. https://doi.org/10.1111/j.1600-051X.2004.00564.x

Moore S, Randhawa M, Ide M. A case-control study to investigate an association between adverse pregnancy outcome and periodontal disease. J Clin Periodontol. 2005 ;32(1):1-5. https://doi.org/10.1111/j.1600-051X.2004.00598.x

Marin C, Segura-Egea JJ, Martínez-Sahuquillo A, Bullón P. Correlation between infant birth weight and mother's periodontal status. J Clin Periodontol. 2005 ;32(3):299-304. https://doi.org/10.1111/j.1600-051X.2005.00661.x

Moreu G, Téllez L, González-Jaranay M. Relationship between maternal periodontal disease and low-birth-weight pre-term infants. J Clin Periodontol. 2005 ;32(6):622-7. https://doi.org/10.1111/j.1600-051X.2005.00722.x

López NJ, Da Silva I, Ipinza J, Gutiérrez J. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy-associated gingivitis. J Periodontol. 2005 ;76(11 Suppl):2144-53. https://doi.org/10.1902/jop.2005.76.11-S.2144

Radnai M, Gorzó I, Urbán E, Eller J, Novák T, Pál A. Possible association between mother's periodontal status and preterm delivery. J Clin Periodontol. 2006 ;33(11):791-6. https://doi.org/10.1111/j.1600-051X.2006.00986.x

Bosnjak A, Relja T, Vucićević-Boras V, Plasaj H, Plancak D. Preterm delivery and periodontal disease: a case-control study from Croatia. J Clin Periodontol. 2006 ;33(10):710-6. https://doi.org/10.1111/j.1600-051X.2006.00977.x

Skuldbøl T, Johansen KH, Dahlén G, Stoltze K, Holmstrup P. Is preterm labour associated with periodontitis in a Danish maternity ward? J Clin Periodontol. 2006 ;33(3):177-83. https://doi.org/10.1111/j.1600-051X.2006.00899.x

Farrell S, Ide M, Wilson RF. The relationship between maternal periodontitis, adverse pregnancy outcome and miscarriage in never smokers. J Clin Periodontol. 2006 ;33(2):115-20. https://doi.org/10.1111/j.1600-051X.2005.00884.x

Santos-Pereira SA, Giraldo PC, Saba-Chujfi E, Amaral RL, Morais SS, Fachini AM, Gonçalves AK. Chronic periodontitis and preterm labour in Brazilian pregnant women: an association to be analysed. J Clin Periodontol. 2007 ;34(3):208-13. https://doi.org/10.1111/j.1600-051X.2006.01038.x

Gomes-Filho IS, Cruz SS, Rezende EJ, Dos Santos CA, Soledade KR, Magalhães MA, de Azevedo AC, Trindade SC, Vianna MI, Passos Jde S, Cerqueira EM. Exposure measurement in the association between periodontal disease and prematurity/low birth weight. J Clin Periodontol 2007 ;34(11):957-63. https://doi.org/10.1111/j.1600-051X.2007.01141.x

Norkhafizah Saddki, Norsa'adah Bachok, Nik Hazlina Nik Hussain, Siti Lailatul Akmar Zainudin, Wihaskoro Sosroseno. The association between maternal periodontitis and low birth weight infants among Malay women. Community Dent Oral Epidemiol 2007. 217.

Pitiphat W, Joshipura KJ, Gillman MW, Williams PL, Douglass CW and Rich- Edwards JW. Maternal Periodontitis and Adverse Pregnancy Outcomes. Community Dent Oral Epidemiol 2007. https://doi.org/10.1111/j.1600-0528.2006.00363.x

Bassani DG, Olinto MT, Kreiger N. Periodontal disease and perinatal outcomes: a case-control study. J Clin Periodontol. 2007 ;34(1):31-9. https://doi.org/10.1111/j.1600-051X.2006.01012.x

Toygar HU, Seydaoglu G, Kurklu S, Guzeldemir E, Arpak N. Periodontal health and adverse pregnancy outcome in 3,576 Turkish women. J Periodontol. 2007 ;78(11):2081-94. https://doi.org/10.1902/jop.2007.070092

Agueda A, Ramón JM, Manau C, Guerrero A, Echeverría JJ. Periodontal disease as a risk factor for adverse pregnancy outcomes: a prospective cohort study. J Clin Periodontol 2007. https://doi.org/10.1111/j.1600-051X.2007.01166.x

Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198(1):7-22. https://doi.org/10.1016/j.ajog.2007.07.040

Offenbacher S, Lin D, Strauss R, McKaig R, Irving J, Barros SP, Moss K, Barrow DA, Hefti A, Beck JD. Effects of periodontal therapy during pregnancy on periodontal status, biologic parameters, and pregnancy outcomes: a pilot study. J Periodontol. 2006 Dec;77(12):2011-24. https://doi.org/10.1902/jop.2006.060047

Tarannum F, Faizuddin M. Effect of periodontal therapy on pregnancy outcome in women affected by periodontitis. J Periodontol. 2007 Nov;78(11):2095-103. https://doi.org/10.1902/jop.2007.060388

Gazolla CM, Ribeiro A, Moysés MR, Oliveira LA, Pereira LJ, Sallum AW. Evaluation of the incidence of preterm low birth weight in patients undergoing periodontal therapy. J Periodontol. 2007 May;78(5):842-8. https://doi.org/10.1902/jop.2007.060295

Renvert S, Badersten A, Nilvéus R, Egelberg J. Healing after treatment of periodontal intraosseous defects. I. Comparative study of clinical methods. J Clin Periodontol. 1981 Oct;8(5):387-99. https://doi.org/10.1111/j.1600-051X.1981.tb00888.x

Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J Clin Periodontol. 1984 Jan;11(1):63-76. https://doi.org/10.1111/j.1600-051X.1984.tb01309.x

Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. III. Single versus repeated instrumentation. J Clin Periodontol. 1984 ;11(2):114-24. https://doi.org/10.1111/j.1600-051X.1984.tb00839.x

Badersten A, Nilvéus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol. 1981 ;8(1):57-72. https://doi.org/10.1111/j.1600-051X.1981.tb02024.x

Badersten A, Nilvéus R, Egelberg J. Scores of plaque, bleeding, suppuration and probing depth to predict probing attachment loss. 5 years of observation following nonsurgical periodontal therapy. J Clin Periodontol. 1990 Feb;17(2):102-7. https://doi.org/10.1111/j.1600-051X.1990.tb01070.x

Rosén B, Olavi G, Badersten A, Rönström A, Söderholm G, Egelberg J. Effect of different frequencies of preventive maintenance treatment on periodontal condiRelación entre enfermedad periodontal y las complicaciones durante el embarazo 218 Aplicación de un modelo biopsicosocial para la reducción de la morbilidad y la mortalidad materna y perinatal en Colombia tions. 5-year observations in general dentistry patients. J Clin Periodontol. 1999 Apr;26(4):225-33. https://doi.org/10.1034/j.1600-051X.1999.260405.x

Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol. 2007 ;34(3):243-53. ttps://doi.org/10.1111/j.1600-051X.2006.01040.x

Teles RP, Bogren A, Patel M, Wennstrom JL, Socransky SS, Haffajee AD. A three-year prospective study of adult subjects with gingivitis II: microbiological parameters. J Clin Periodontol. 2007 Jan;34(1):7-17. https://doi.org/10.1111/j.1600-051X.2006.01015.x

Ogren A, Teles R, Torresyap G, Haffajee AD, Socransky SS, Lindhe J, Wennström JL. A three-year prospective study of adult subjects with gingivitis. I: clinical periodontal parameters. J Clin Periodontol. 2007 Jan;34(1):1-6. https://doi.org/10.1111/j.1600-051X.2006.01000.x

Haffajee AD, Teles RP, Socransky SS. The effect of periodontal therapy on the composition of the subgingival microbiota. Periodontol 2000. 2006;42:219-58. https://doi.org/10.1111/j.1600-0757.2006.00191.x

Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol 2000. 2006;42:180-218. https://doi.org/10.1111/j.1600-0757.2006.00192.x

Moutsopoulos NM, Madianos PN. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann N Y Acad Sci. 2006 Nov;1088:251-64. https://doi.org/10.1196/annals.1366.032

Andrews WW, Goldenberg RL, Hauth JC. Preterm labor: Emerging role of genital tract infections. Infect Agents Dis 1995;4:196-211.

Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for premature rupture of membranes: A prospective study of the vagina flora in pregnancy. Am J Obstet Gynecol 1984;150:965-972. https://doi.org/10.1016/0002-9378(84)90392-2

Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokström H, Holst RM, Nikolaitchouk N, Wennerholm UB, Hagberg H. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand. 2003 May;82(5):423-31. https://doi.org/10.1034/j.1600-0412.2003.00157.x

Buduneli N, Baylas H, Buduneli E, Türkoğlu O, Köse T, Dahlen G. Periodontal infections and pre-term low birth weight: a case-control study. J Clin Periodontol. 2005 Feb;32(2):174-81. https://doi.org/10.1111/j.1600-051X.2005.00670.x

León R, Silva N, Ovalle A, Chaparro A, Ahumada A, Gajardo M, Martinez M, Gamonal J. Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2007 Jul;78(7):1249-55. https://doi.org/10.1902/jop.2007.060368

Barak S, Oettinger-Barak O, Machtei EE, Sprecher H, Ohel G. Evidence of periopathogenic microorganisms in placentas of women with preeclampsia. J Periodontol. 2007 Apr;78(4):670-6. 219. https://doi.org/10.1902/jop.2007.060362

Madianos PN, Lieff S, Murtha AP, Boggess KA, et al. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. Ann Periodontol 2001;6:175-182. https://doi.org/10.1902/annals.2001.6.1.175

Lin D, Moss K, Beck JD, Hefti A, Offenbacher S. Persistently high levels of periodontal pathogens associated with preterm pregnancy outcome. J Periodontol. 2007 May;78(5):833-41. https://doi.org/10.1902/jop.2007.060201

Dasanayake AP, Boyd D, Madianos PN, Offenbacher S, Hills E. The association between Porphyromonas gingivalis-specific maternal serum IgG and low birth weight. J Periodontol. 2001 Nov;72(11):1491-7.

https://doi.org/10.1902/jop.2001.72.11.1491

Simor AE, Karmali MA, Jadavji T, Rose M. Abortion and perinatal sepsis associated with Campylobacter infection. Rev Infect Dis 1986;8:397-401.

O'Sullivan AM, Dore CJ, Boyle S, Coid CR, Johnson AP. The effect of Campylobacter lipopolysaccharide on fetal development in the mouse. J Med Microbiol 1988; 26:101-105. https://doi.org/10.1099/00222615-26-2-101

O'Sullivan AM, Dore CJ, Boyle S, Coid CR. Campylobacters and impaired fetal development in mice. J Med Microbiol 1988;25:7-12. https://doi.org/10.1099/00222615-25-1-7

Lin DM, Smith MA, Champagne C, Elter J, Beck JD, Offenbacher, S. Porphyromonas gingivalis infection during pregnancy increases maternal TNF-α, suppresses maternal IL-10, and enhances fetal growth restriction and resorption in mice. Infect Immun 2003;71:5156-5162. https://doi.org/10.1128/IAI.71.9.5156-5162.2003

Yeo A, Smith MA, Lin D, Riché EL, Moore A, Elter J, Offenbacher S. Campylobacter rectus mediates growth restriction in pregnant mice. J Periodontol. 2005 Apr;76(4):551-7. https://doi.org/10.1902/jop.2005.76.4.551

Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, et al. Association of polymorphism within the promoter of the tumour necrosis factor a gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:1297- 1302. https://doi.org/10.1016/S0002-9378(99)70632-0

Moore S, Ide M, Randhawa M, Walker JJ, Reid JG, Simpson NA. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG. 2004 Feb;111(2):125-32.

https://doi.org/10.1046/j.1471-0528.2003.00024.x-i1

Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and proinflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001;75:243-249.

https://doi.org/10.1016/S0020-7292(01)00499-4

Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003;59:29-37. https://doi.org/10.1016/S0165-0378(02)00085-2

Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162:1-6. https://doi.org/10.1093/aje/kwi323

Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol. 2005 Dec 1;162(11):1108-13.

Pitiphat W, Joshipura KJ, Rich-Edwards JW, Williams PL, Douglass CW, Gillman MW. Periodontitis and plasma C-reactive protein during pregnancy. J Periodontol. 2006 May;77(5):821-5. https://doi.org/10.1902/jop.2006.050193

Herrera JA, Parra B, Herrera E, Botero JE, Arce RM, Contreras A, López-Jaramillo P. Periodontal disease severity is related to high levels of C-reactive protein in preeclampsia. J Hypertens. 2007 Jul;25(7):1459-64.

https://doi.org/10.1097/HJH.0b013e3281139ea9

Pitiphat W, Savetsilp W, Wara-Aswapati N. C-reactive protein associated with periodontitis in a Thai Population. J Clin Periodontol. 2007. https://doi.org/10.1111/j.1600-051X.2007.01179.x

CAPÍTULO 16:

Herrera JA & Hurtado H, Cáceres D. Antepartum biopsychosocial risk and perinatal outcome. Fam Pract Res J 1992; 12: 391-399.

Herrera JA. La mortalidad perinatal y el modelo biopsicosocial. Experiencias institucionales en Colombia. Atención Prim 1992; 10: 992.

Herrera JA, Alvarado JP & Restrepo W. Riesgo biopsicosocial prenatal y preeclampsia. Atenc Primaria 1995; 16:9,552-55.

Herrera JA, Salmerón B., Hurtado H. The biopsychosocial risk assessment and the low birthweight. Soc Sci Med 1997; 44:8, 1107-14. https://doi.org/10.1016/S0277-9536(96)00240-7

CAPÍTULO 17:

Maternal Mortality in 2000 - Estimates Developed by WHO, UNICEF and UNFPA. UNICEF Statistics: tomado de http://childinfo.org/areas/maternalmortality/ el 9 de febrero de 2008.

Fondo de Población de las Naciones Unidas. Evolución y estado actual de la mortalidad materna en Colombia, 2001.

DANE. Mortalidad en Colombia, 1998, Bogotá D.C.

Ministerio de la Protección Social, República de Colombia. Indicadores Básicos de Salud 2002.

Gaitán H. et al. Tamizaje de eventos adversos en atención obstétrica y del puerperio en el Instituto Materno Infantil de Bogotá, Colombia 2002 - 2003, Rev Col Obstet Ginec 2005; 56 (1): 17-18. https://doi.org/10.18597/rcog.555

CRUE - Valle. Evitabilidad hospitalaria en el registro de referencia del CRUE Valle. Estadísticas: Tomado de http://www.cruevalle.com/ el 5 de febrero de 2008.